Rivaroxaban recanalized occlusive superior mesenteric vein thrombosis, but increased the risk of bleeding in a cirrhotic patient
Liver Int
.
2017 Oct;37(10):1574-1575.
doi: 10.1111/liv.13511.
Epub 2017 Jul 21.
Authors
Xingshun Qi
1
,
Eric M Yoshida
2
,
Nahum Mendez-Sanchez
3
,
Xiaozhong Guo
1
Affiliations
1
Liver Cirrhosis Study Group, Department of Gastroenterology, General Hospital of Shenyang Military Area, Shenyang, Liaoning Province, China.
2
Division of Gastroenterology, Vancouver General Hospital, Vancouver, British Columbia, Canada.
3
Liver Research Unit Medica Sur Clinic & Foundation, Mexico City, Mexico.
PMID:
28675619
DOI:
10.1111/liv.13511
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Liver Cirrhosis
Mesenteric Ischemia
Mesenteric Veins*
Portal Vein
Rivaroxaban*
Thrombosis
Venous Thrombosis
Substances
Rivaroxaban